Castle Biosciences, Inc. (CSTL)

USD 19.35

(0.21%)

Revenue Summary of Castle Biosciences, Inc.

  • Castle Biosciences, Inc.'s latest annual revenue in 2023 was 219.78 Million USD , up 60.38% from previous year.
  • Castle Biosciences, Inc.'s latest quarterly revenue in 2024 Q2 was 87 Million USD , up 19.22% from previous quarter.
  • Castle Biosciences, Inc. reported a annual revenue of 137.03 Million USD in annual revenue 2022, up 45.65% from previous year.
  • Castle Biosciences, Inc. reported a annual revenue of 94.08 Million USD in annual revenue 2021, up 50.18% from previous year.
  • Castle Biosciences, Inc. reported a quarterly revenue of 87 Million USD for 2024 Q2, up 19.22% from previous quarter.
  • Castle Biosciences, Inc. reported a quarterly revenue of 72.97 Million USD for 2024 Q1, up 10.37% from previous quarter.

Annual Revenue Chart of Castle Biosciences, Inc. (2023 - 2017)

Historical Annual Revenue of Castle Biosciences, Inc. (2023 - 2017)

Year Revenue Revenue Growth
2023 219.78 Million USD 60.38%
2022 137.03 Million USD 45.65%
2021 94.08 Million USD 50.18%
2020 62.64 Million USD 20.79%
2019 51.86 Million USD 127.62%
2018 22.78 Million USD 65.67%
2017 13.75 Million USD 0.0%

Peer Revenue Comparison of Castle Biosciences, Inc.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -603.344%
Biodesix, Inc. 49.08 Million USD -347.752%
bioAffinity Technologies, Inc. 2.53 Million USD -8578.7%
DarioHealth Corp. 20.35 Million USD -979.933%
Exact Sciences Corporation 2.49 Billion USD 91.208%
IDEXX Laboratories, Inc. 3.66 Billion USD 93.996%
Illumina, Inc. 4.5 Billion USD 95.12%
Intelligent Bio Solutions Inc. 3.11 Million USD -6963.093%
iSpecimen Inc. 9.92 Million USD -2113.778%
Standard BioTools Inc. 106.34 Million USD -106.684%
23andMe Holding Co. 219.63 Million USD -0.068%
Medpace Holdings, Inc. 1.88 Billion USD 88.345%
NeoGenomics, Inc. 591.64 Million USD 62.851%
Inotiv, Inc. 572.42 Million USD 61.604%
Psychemedics Corporation 22.09 Million USD -894.606%
Prenetics Global Limited 21.74 Million USD -910.86%
Precipio, Inc. 15.19 Million USD -1346.259%
RadNet, Inc. 1.61 Billion USD 86.405%
Sotera Health Company 1.04 Billion USD 79.054%
Star Equity Holdings, Inc. 45.78 Million USD -380.044%
Exagen Inc. 52.54 Million USD -318.261%
Natera, Inc. 1.08 Billion USD 79.698%
Aspira Women's Health Inc. 9.15 Million USD -2301.005%
Neogen Corporation 924.22 Million USD 76.219%
Myriad Genetics, Inc. 678.4 Million USD 67.602%
ICON Public Limited Company 8.12 Billion USD 97.293%
Bionano Genomics, Inc. 36.11 Million USD -508.561%
CareDx, Inc 280.32 Million USD 21.595%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 29.774%
Guardant Health, Inc. 563.94 Million USD 61.027%
BioNexus Gene Lab Corp. 9.77 Million USD -2149.436%
Fulgent Genetics, Inc. 289.21 Million USD 24.005%
Sera Prognostics, Inc. 306 Thousand USD -71726.144%
OPKO Health, Inc. 863.49 Million USD 74.547%
Personalis, Inc. 73.48 Million USD -199.109%
Applied DNA Sciences, Inc. 13.36 Million USD -1544.204%
Star Equity Holdings, Inc. 45.78 Million USD -380.044%
MDxHealth SA 70.19 Million USD -213.12%
Prenetics Global Limited 21.74 Million USD -910.86%
ENDRA Life Sciences Inc. - USD -Infinity%
Mainz Biomed B.V. 895.47 Thousand USD -24444.182%
Trinity Biotech plc 56.83 Million USD -286.733%
Neuronetics, Inc. 71.34 Million USD -208.051%
bioAffinity Technologies, Inc. 2.53 Million USD -8578.7%